The IMPACT study is going to be an international multi-centre retrospective study of patients with an incidental intracranial meningioma. The primary aim of the study will be to externally validate and calibrate a prognostic model of radiological and clinical progression – IMPACT (Incidental Meningioma: Prognostic Analysis Using Patient Comorbidity and MRI Tests) https://www.impact-meningioma.com.
The study will include patients with an incidental intracranial meningioma diagnosed between 01/01/2009 and 31/12/2010. Data will be recorded until death or last date of follow-up.
The study is due to begin in September 2020 and we are now asking for local collaborators to sign up.
If you would like to register your interest, then please complete the form below.
Study lead: Abed Islim email@example.com
IMPACT study protocol